SS Innovations International (SSII) Interest & Investment Income (2016 - 2026)
SS Innovations International (SSII) reported Interest & Investment Income of $491589.0 for Q1 2026, down 20.76% on a YoY basis from $620405.0 in Q1 2025, and up 34.84% sequentially from $364566.0 in Q4 2025.
SS Innovations International (SSII) Interest & Investment Income (2016 - 2026) Analysis & Trends
SS Innovations International (SSII) has 10 years of Interest & Investment Income data on file, last reported at $491589.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 20.76% year-over-year to $491589.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 1.92% YoY), and the FY2025 full-year result was $1.1 million, up 43.07% from the prior year.
- Interest & Investment Income advanced to $491589.0 in Q1 2026, from $364566.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $620405.0 in Q1 2025 to a low of $29.0 in Q2 2022.
- A 5-year average of $171094.7 and a median of $155953.0 in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income jumped 392626.09% in 2024 and tumbled 31.85% in 2025, its largest moves.
- Tracing SSII's Interest & Investment Income over 5 years: stood at $42.0 in 2022, then surged by 371216.67% to $155953.0 in 2023, then jumped by 33.53% to $208249.0 in 2024, then surged by 75.06% to $364566.0 in 2025, then surged by 34.84% to $491589.0 in 2026.
- Business Quant data shows SSII's Interest & Investment Income at $491589.0 in Q1 2026, $364566.0 in Q4 2025, and $141002.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | SS Innovations International | 776.19 Mn | 752.58 Mn | 5.33 Mn | 491,589.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 491,589.00 |
| Dec 31, 2025 | 364,566.00 |
| Sep 30, 2025 | 141,002.00 |
| Jun 30, 2025 | 216,824.00 |
| Mar 31, 2025 | 620,405.00 |
| Dec 31, 2024 | 208,249.00 |
| Sep 30, 2024 | 206,901.00 |
| Jun 30, 2024 | 202,196.00 |
| Mar 31, 2024 | 180,654.00 |
| Dec 31, 2023 | 155,953.00 |
| Sep 30, 2023 | 88,225.00 |
| Jun 30, 2023 | 31,852.00 |
| Mar 31, 2023 | 46.00 |
| Dec 31, 2022 | 42.00 |
| Sep 30, 2022 | 42.00 |
| Jun 30, 2022 | 29.00 |
| Mar 31, 2022 | 35.00 |
| Dec 31, 2021 | 29.00 |
| Sep 30, 2021 | 29.00 |
| Jun 30, 2021 | 38.00 |